In a plenary session at EAS 2022 titled 'From lifestyle to designer therapies' chaired by Christoph J. Binder, Austria and Maciej Banach, Poland, experts discussed certain aspects of cardiovascular disease (CVD) prevention beyond pharmacotherapy.
CVD prevention at population level (Salim Yusuf, Canada)
The three major modifiable causes of vascular mortality...